Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brandon M Huffman

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Cancers|December 10, 2021
Early <i>TP53</i> Alterations Shape Gastric and Esophageal Cancer DevelopmentPranshu Sahgal, Brandon M Huffman, Deepa T Patil, et al.
Clinical Colorectal Cancer|June 11, 2019
Novel Prognostic Factors in Resected Small Bowel AdenocarcinomaBrandon M Huffman, Zhaohui Jin, Siddhartha Yadav, et al.
Journal of Gastrointestinal Oncology|April 30, 2019
Local excision for patients with stage I anal canal squamous cell carcinoma can be curativeSakti Chakrabarti, Zhaohui Jin, Brandon M Huffman, et al.
Pancreas|April 12, 2019
Solid Pseudopapillary Neoplasms of the Pancreas: A Large American CohortCristobal T Sanhueza, Brandon M Huffman, Zhaohui Jin, et al.
Journal of Gastrointestinal Oncology|June 12, 2019
Clinicopathological features and outcomes of fibrolamellar hepatocellular carcinomaSakti Chakrabarti, Sri Harsha Tella, Anuhya Kommalapati, et al.
NPJ Precision Oncology|September 2, 2022
Secondary IDH1 resistance mutations and oncogenic IDH2 mutations cause acquired resistance to ivosidenib in cholangiocarcinomaJames M Cleary, Betty Rouaisnel, Antoine Daina, et al.
JCO Precision Oncology|December 6, 2024
Circulating Tumor DNA as a Prognostic Biomarker for Recurrence in Patients With Locoregional Esophagogastric Cancers With a Pathologic Complete ResponseEric Michael Lander, Vasily N Aushev, Brandon M Huffman, et al.
Cancers|December 23, 2022
Emerging Role of Targeted Therapy in Metastatic Pancreatic AdenocarcinomaBrandon M Huffman, Haley Ellis, Alexander C Jordan, et al.
The American Journal of Surgical Pathology|May 10, 2024
Transcriptionally Active Human Papillomavirus Infection in a Minority of Esophageal Squamous Cell Carcinomas in North AmericaAnna H Bauer, Khaled J Alkhateeb, Agoston T Agoston, et al.
JAMA Network Open|January 5, 2023
Effect of a MUC5AC Antibody (NPC-1C) Administered With Second-Line Gemcitabine and Nab-Paclitaxel on the Survival of Patients With Advanced Pancreatic Ductal Adenocarcinoma: A Randomized Clinical TrialBrandon M Huffman, Atrayee Basu Mallick, Nora K Horick, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Cancers|December 10, 2021
Early <i>TP53</i> Alterations Shape Gastric and Esophageal Cancer DevelopmentPranshu Sahgal, Brandon M Huffman, Deepa T Patil, et al.
Clinical Colorectal Cancer|June 11, 2019
Novel Prognostic Factors in Resected Small Bowel AdenocarcinomaBrandon M Huffman, Zhaohui Jin, Siddhartha Yadav, et al.
Journal of Gastrointestinal Oncology|April 30, 2019
Local excision for patients with stage I anal canal squamous cell carcinoma can be curativeSakti Chakrabarti, Zhaohui Jin, Brandon M Huffman, et al.
Pancreas|April 12, 2019
Solid Pseudopapillary Neoplasms of the Pancreas: A Large American CohortCristobal T Sanhueza, Brandon M Huffman, Zhaohui Jin, et al.
Journal of Gastrointestinal Oncology|June 12, 2019
Clinicopathological features and outcomes of fibrolamellar hepatocellular carcinomaSakti Chakrabarti, Sri Harsha Tella, Anuhya Kommalapati, et al.
NPJ Precision Oncology|September 2, 2022
Secondary IDH1 resistance mutations and oncogenic IDH2 mutations cause acquired resistance to ivosidenib in cholangiocarcinomaJames M Cleary, Betty Rouaisnel, Antoine Daina, et al.
JCO Precision Oncology|December 6, 2024
Circulating Tumor DNA as a Prognostic Biomarker for Recurrence in Patients With Locoregional Esophagogastric Cancers With a Pathologic Complete ResponseEric Michael Lander, Vasily N Aushev, Brandon M Huffman, et al.
Cancers|December 23, 2022
Emerging Role of Targeted Therapy in Metastatic Pancreatic AdenocarcinomaBrandon M Huffman, Haley Ellis, Alexander C Jordan, et al.
The American Journal of Surgical Pathology|May 10, 2024
Transcriptionally Active Human Papillomavirus Infection in a Minority of Esophageal Squamous Cell Carcinomas in North AmericaAnna H Bauer, Khaled J Alkhateeb, Agoston T Agoston, et al.
JAMA Network Open|January 5, 2023
Effect of a MUC5AC Antibody (NPC-1C) Administered With Second-Line Gemcitabine and Nab-Paclitaxel on the Survival of Patients With Advanced Pancreatic Ductal Adenocarcinoma: A Randomized Clinical TrialBrandon M Huffman, Atrayee Basu Mallick, Nora K Horick, et al.
Pageof 4